SHIGERU AND CANNSUN ESTABLISH A JOINT VENTURE COMPANY AS EU GMP-BASED CBD PLATFORM IN JAPAN
Share This Article CAPE TOWN , SOUTH AFRICA , April 26, 2021 /EINPresswire.com/ -- Cannsun Group PLC ("Cannsun"), a bio-pharmaceutical company focused on developing and commercializing new medicines to optimize human potential with operations in South Africa, Greece, Japan, Thailand and Lesotho. Cannsun Group PLC is pleased to announce its establishment of its Joint Venture company with SHIGERU GmbH that has been established as Technology Transfer venture capital supported by Basel government of Switzerland, hereafter called “Shigeru”, headquarters in Tokyo Japan, and re...
Source: einnews.com